期刊文献+

转移性结直肠癌的治疗进展 被引量:2

下载PDF
导出
摘要 根据世界卫生组织国际癌症研究机构(IARC)报道,2020年,结直肠癌(colorectal cancer,CRC)新发病例约193万例,死亡近93.5万例,为人类社会发展带来沉重的负担[1]。肿瘤转移是CRC患者预后不良一个重要原因,约1/4 CRC患者在确诊时已经发生转移,即转移性结直肠癌(metastatic colorectal cancer,mCRC)。CRC最常见的转移是肝、肺和腹膜转移[2]。
作者 黄琪 孙敬平
出处 《成都医学院学报》 CAS 2022年第2期258-262,共5页 Journal of Chengdu Medical College
基金 四川省科技厅项目(No:2019YJ0582) 四川省教育厅科研项目(No:17ZA0122)。
  • 相关文献

参考文献6

二级参考文献154

  • 1李云峰,李文亮,叶盛威,李强,栗明,夏翠峰,蔡昕怡.结直肠癌切除同期射频消融肝转移的临床应用[J].中华肿瘤防治杂志,2006,13(9):717-718. 被引量:4
  • 2Wendy De Roock,Bart Claes,David Bernasconi,Jef De Schutter,Bart Biesmans,George Fountzilas,Konstantine T Kalogeras,Vassiliki Kotoula,Demetris Papamichael,Pierre Laurent-Puig,Frédérique Penault-Llorca,Philippe Rougier,Bruno Vincenzi,Daniele Santini,Giuseppe Tonini,Federico Cappuzzo,Milo Frattini,Francesca Molinari,Piercarlo Saletti,Sara De Dosso,Miriam Martini,Alberto Bardelli,Salvatore Siena,Andrea Sartore-Bianchi,Josep Tabernero,Teresa Macarulla,Frédéric Di Fiore,Alice Oden Gangloff,Fortunato Ciardiello,Per Pfeiffer,Camilla Qvortrup,Tine Plato Hansen,Eric Van Cutsem,Hubert Piessevaux,Diether Lambrechts,Mauro Delorenzi,Sabine Tejpar.Effects of KRAS, BRAF, NRAS , and PIK3CA mutations on the efficacy of cetuximab plus chemotherapy in chemotherapy-refractory metastatic colorectal cancer: a retrospective consortium analysis[J].Lancet Oncology.2010(8)
  • 3Wendy De Roock,Veerle De Vriendt,Nicola Normanno,Fortunato Ciardiello,Sabine Tejpar.KRAS , BRAF , PIK3CA , and PTEN mutations: implications for targeted therapies in metastatic colorectal cancer[J].Lancet Oncology.2011(6)
  • 4Yan-Jie Zhang,Xiao-Qing Tian,Dan-Feng Sun,Shu-Liang Zhao,Hua Xiong,Jing-Yuan Fang.Combined Inhibition of MEK and mTOR Signaling Inhibits Initiation and Progression of Colorectal Cancer[J].Cancer Investigation.2009(3)
  • 5Lindsey A. Torre,Freddie Bray,Rebecca L. Siegel,Jacques Ferlay,Joannie Lortet‐Tieulent,Ahmedin Jemal.Global cancer statistics, 2012[J]. CA: A Cancer Journal for Clinicians . 2015 (2)
  • 6Hynes NE,Lane HA.ERBB receptors and cancer: the complexity of targeted inhibitors. Nature Reviews Cancer . 2005
  • 7Liao Xiaoyun,Lochhead Paul,Nishihara Reiko,Morikawa Teppei,Kuchiba Aya,Yamauchi Mai,Imamura Yu,Qian Zhi Rong,Baba Yoshifumi,Shima Kaori,Sun Ruifang,Nosho Katsuhiko,Meyerhardt Jeffrey A,Giovannucci Edward,Fuchs Charles S,Chan Andrew T,Ogino.Aspirin use, tumor PIK3CA mutation, and colorectal-cancer survival. The New England Quarterly . 2012
  • 8Donna M. Muzny,Matthew N. Bainbridge,Kyle Chang.Comprehensive molecular characterization of human colon and rectal cancer. Nature . 2012
  • 9Sansal I,Sellers WR.The biology and clinical relevance of the PTEN tumor suppressor pathway. Journal of Clinical Oncology . 2004
  • 10Karapetis Christos S,Khambata-Ford Shirin,Jonker Derek J,O’Callaghan Chris J,Tu Dongsheng,Tebbutt Niall C,Simes R John,Chalchal Haji,Shapiro Jeremy D,Robitaille Sonia,Price Timothy J,Shepherd Lois,Au Heather-Jane,Langer Christiane,Moore Malc.K-ras mutations and benefit from cetuximab in advanced colorectal cancer. The New England Quarterly . 2008

共引文献19

同被引文献34

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部